ConductScience.org, home

Paper853532

Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks.

Albert RE and 2 others. J Natl Cancer Inst, 1977. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks. Papers, record 853532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/853532

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Albert RER E
2Train RER E
3Anderson EE

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinogens, EnvironmentalMajor topic
Government AgenciesMajor topic
NeoplasmsMajor topic
Environmental Exposure
Epidemiologic Methods
Female
Humans
Male
Research Design
Risk
United States

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
38715588Collaborative Study of Thresholds for Mutagens: Adaptive Responses in the Micronucleus Test and Gene Induction by Mutagenic Treatments.Dose Response2024https://conductscience.org/library/papers/38715588PubMed
38293450Physicochemical and pharmacotechnical characterization of Prussian blue for future Prussian blue oral dosage forms formulation.Heliyon2024https://conductscience.org/library/papers/38293450PubMed
32356927Consideration of the Aerosol Transmission for COVID-19 and Public Health.Risk Anal2020https://conductscience.org/library/papers/32356927PubMed
30783394When Risk Assessment Came to Washington: A Look Back.Dose Response2019https://conductscience.org/library/papers/30783394PubMed
29051718The Mistaken Birth and Adoption of LNT: An Abridged Version.Dose Response2017https://conductscience.org/library/papers/29051718PubMed
28696207Levels and Determinants of DDT and DDE Exposure in the VHEMBE Cohort.Environ Health Perspect2017https://conductscience.org/library/papers/28696207PubMed
28266262Using exposure bands for rapid decision making in the RISK21 tiered exposure assessment.Crit Rev Toxicol2017https://conductscience.org/library/papers/28266262PubMed
28265305The 10th anniversary of the publication of genes and environment: memoir of establishing the Japanese environmental mutagen society and a proposal for a new collaborative study on mutagenic hormesis.Genes Environ2017https://conductscience.org/library/papers/28265305PubMed
19223660Probabilistic exposure analysis for chemical risk characterization.Toxicol Sci2009https://conductscience.org/library/papers/19223660PubMed
17520071If cumulative risk assessment is the answer, what is the question?Environ Health Perspect2007https://conductscience.org/library/papers/17520071PubMed
6993199Human health hazards associated with chemical contamination of aquatic environment.Environ Health Perspect1980https://conductscience.org/library/papers/6993199PubMed
6186474Consensus report: mutagenicity and carcinogenicity of car exhausts and coal combustion emissions.Environ Health Perspect1983https://conductscience.org/library/papers/6186474PubMed
1781734Arsenic: opportunity for risk assessment.Arch Toxicol1991https://conductscience.org/library/papers/1781734PubMed
521448The problem of estimating safe dose levels in chemical carcinogenesis.J Cancer Res Clin Oncol1979https://conductscience.org/library/papers/521448PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/853532

GET https://conductscience.org/api/papers/v1/853532/authors